about
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rh2015 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac Electrophysiology (A Revision of the ACC/AHA 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion)Device-detected atrial fibrillation: what to do with asymptomatic patients?2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationDefibrillators: Selecting the Right Device for the Right Patient.A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.American Heart Association atrial fibrillation research summit: a conference report from the American Heart AssociationSmartDelay determined AV optimization: a comparison of AV delay methods used in cardiac resynchronization therapy (SMART-AV): rationale and design.Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: meta-analysis of randomized trials, using individual patient data.Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial (MOST).Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenoson.AHA/ACCF scientific statement on the evaluation of syncope: from the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research IACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 GuiACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.Ventricular Arrhythmias in Apparently Normal Hearts: Who Needs an Implantable Cardiac Defibrillator?Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions.Outcomes in African Americans undergoing cardioverter-defibrillator implantation for primary prevention of sudden cardiac death: findings from the Prospective Observational Study of Implantable Cardioverter-Defibrillators (PROSE-ICD).A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on PracticeManagement of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.Clinical and serum-based markers are associated with death within 1 year of de novo implant in primary prevention ICD recipients.Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).Resynchronization therapy for the treatment of heart failure.The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy.Evidence base for pacemaker mode selection: from physiology to randomized trials.Changes in Follow-Up Left Ventricular Ejection Fraction Associated With Outcomes in Primary Prevention Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Device Recipients.Clinical competency statement: Training pathways for implantation of cardioverter defibrillators and cardiac resynchronization devices.Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004.Abnormal Left Ventricular Mechanics of Ventricular Ectopic Beats: Insights Into Origin and Coupling Interval in Premature Ventricular Contraction-Induced CardiomyopathyPredictors of mortality, LVAD implant, or heart transplant in primary prevention cardiac resynchronization therapy recipients: The HF-CRT score.Clinical decision tool for CRT-P vs. CRT-D implantation: Findings from PROSE-ICD.Prospective observational study of implantable cardioverter-defibrillators in primary prevention of sudden cardiac death: study design and cohort description.A review of spinal injuries in the invasive cardiologist: part 1. Biomechanics and pain generation.A review of spinal injuries in the invasive cardiologist II: prevention and treatment.
P50
Q22306351-38CEEFD0-9D00-4F0C-9DE3-D5CC1032BF85Q22306360-52E7A7C0-7867-403D-A803-D76615710ACEQ26782673-F41715ED-26D5-44DA-BE2F-E2F93B18D757Q28087510-7BC7DC39-19E9-458F-8587-28DC351F4157Q28305368-D689E4AA-C1D3-4F5E-BBEC-BADF96D225D7Q28307011-BA2348CD-E3FB-4E3F-AF0B-8237316C55D6Q30394716-F926136F-2B4D-47E1-969F-7BD4871D59CDQ30407585-29B3CC66-A3A4-4F0A-AB6F-60A770D94864Q30425918-1AAB9CA8-9098-4F23-AAB8-29F8BAEAC548Q30480376-EA95FADD-C914-4BC7-B952-BCEF2883BF77Q31046738-55BEF600-142D-4AC3-AF6A-0FD9EDBE7594Q33148932-C9C52975-B329-418E-93F0-051174132E98Q33151443-B19898D8-2AA4-4622-9BED-348AD6F2DA7EQ33152807-B96B5673-CC63-4F7B-AAC5-FDFF3CFBFCDCQ33153485-9D9D36AF-7461-4388-BBD7-4C4068CA2305Q33156283-652F46EC-6279-4CDA-822C-655D4A380A52Q33156332-D33C9680-5559-48E9-8078-8967C55EB9E5Q33161791-A08B05D1-D654-47B9-B814-2E9300EEB650Q33167587-AA34DBFB-089B-4A51-A543-E874DA2AD141Q33530971-6199FD9C-6BFF-4559-AFFF-7E2C1A7384CFQ33940619-6D1732FE-5886-4AD2-8113-E5BBDB6CE64EQ34164055-1CF2994E-539D-4F26-ACC2-CC95433ADE21Q34211213-90324EA6-CDA8-494D-AA04-38BEFDCD1FEFQ34319426-DF3A78B5-EE8D-47DB-9F27-4642269E350DQ34336306-12F7854A-0D97-4089-8960-A19D1C17E340Q34336306-78B7C82A-C7AA-4FEA-AA32-106C54FAFD89Q34378471-A973DFEF-C3F8-45DB-B2C7-FDE363B1910BQ35001908-BBCB8ABE-48A1-4424-A1EA-A9F1915394A7Q35107904-A07F204D-84E7-4CCA-94E7-B0AA96807630Q35210591-E0F86C20-F68F-47B8-B0F3-7537180E3026Q35367149-B1144855-D449-49E8-B217-74E55DC1B76CQ35646414-452801AC-67DA-4B36-9448-C7BC6D4EE3E2Q35909888-5A2B464F-85DF-4F54-87E6-27D432BCBFC6Q36106007-D94A5C88-0E5A-4ABF-A8E8-A4E175864A3CQ36173999-E7E5845F-1E9C-4CD4-A348-CE0B680B802AQ36199714-F15F848A-D774-4BAF-88A2-65FAB64E8C0CQ36307480-B32AE1DB-A0E5-4206-B59F-1C47EC46B020Q36339905-60EB4662-33F5-46CE-96E3-FDE1FA2EADE9Q36701714-7EE37774-F4C8-4176-9C11-7B197AF83275Q36899139-F954CCE3-8B32-4F35-B76D-BDDC6CEFC7C3
P50
name
Kenneth A Ellenbogen
@en
type
label
Kenneth A Ellenbogen
@en
prefLabel
Kenneth A Ellenbogen
@en